Nuclear Medicine

Pluvictoᵀᴹ Prostate Cancer Treatment

Body

Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) is a targeted prostate cancer treatment. This radioactive medicine is a new option for someone with prostate cancer that has spread to other areas of the body. Pluvicto isn't a cure for cancer. But it can help some men live longer and slow the growth of their tumors.

UVA Health is one of the first hospitals in Virginia to offer this treatment. 

Appointments by referral only.

Is This Treatment Right For Me?

This FDA-approved treatment can help you if you have:

Clinical Practice Terms